Richard Swift - CVS Health Independent Director

CVS Stock  USD 79.43  0.11  0.14%   

Director

Mr. Richard J. Swift is Independent Director of CVS Caremark Corporationration Mr. Swift is the former Chairman of the Board, President and Chief Executive Officer of Foster Wheeler Ltd., an international engineering and construction firm, having served in those positions from April 1994 until his retirement in October 2001. Mr. Swift also served as a member and as Chairman of the Financial Accounting Standards Advisory Council from 2002 until his retirement from FASAC in December 2006 since 2006.
Age 73
Tenure 18 years
Professional MarksMBA
Address One CVS Drive, Woonsocket, RI, United States, 02895
Phone401 765 1500
Webhttps://www.cvshealth.com
Swift is also lead director of IngersollRand plc, a diversified industrial company, and a director of Kaman Corporationrationrationration, a diversified manufacturer and distributor, Hubbell Incorporated, an electrical and electronic products company, and Public Service Enterprise Group Incorporated, an energy company. B.S., U.S. Military Academy at West Point; M.S., Purdue University; M.B.A., Fairleigh Dickinson University.

Richard Swift Latest Insider Activity

Tracking and analyzing the buying and selling activities of Richard Swift against CVS Health stock is an integral part of due diligence when investing in CVS Health. Richard Swift insider activity provides valuable insight into whether CVS Health is net buyers or sellers over its current business cycle. Note, CVS Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell CVS Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

CVS Health Management Efficiency

The company has Return on Asset of 0.0368 % which means that on every $100 spent on assets, it made $0.0368 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1128 %, implying that it generated $0.1128 on every 100 dollars invested. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVS Health's Return On Assets are comparatively stable compared to the past year. Return On Equity is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, CVS Health's Asset Turnover is comparatively stable compared to the past year.
The company has 79.39 B in debt with debt to equity (D/E) ratio of 1.0, which is OK given its current industry classification. CVS Health Corp has a current ratio of 0.92, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist CVS Health until it has trouble settling it off, either with new capital or with free cash flow. So, CVS Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CVS Health Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVS to invest in growth at high rates of return. When we think about CVS Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

John CardisEdwards Lifesciences Corp
73
Ori HershkovitzMedigus Ltd ADR
39
Ramona SequeiraEdwards Lifesciences Corp
55
Moshe ShohamMicrobot Medical
64
Kieran GallahueEdwards Lifesciences Corp
57
Eitan MachoverMedigus Ltd ADR
55
Yair RabinovitchMedigus Ltd ADR
67
Yoav WaizerMicrobot Medical
51
Aviel ShapiraMedigus Ltd ADR
61
Yuval YanaiMedigus Ltd ADR
65
Martin MaddenMicrobot Medical
57
Prattipati LaxminarainMicrobot Medical
59
Doron BirgerMedigus Ltd ADR
66
Leslie HeiszEdwards Lifesciences Corp
60
Nicholas ValerianiEdwards Lifesciences Corp
64
Yair RabinowitchMedigus Ltd ADR
71
Anat NaschitzMedigus Ltd ADR
N/A
Martha MarshEdwards Lifesciences Corp
72
Yoseph BornsteinMicrobot Medical
65
Efrat VenkertMedigus Ltd ADR
46
Barbara McNeilEdwards Lifesciences Corp
74
CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. CVS Health Corp (CVS) is traded on New York Stock Exchange in USA. It is located in One CVS Drive, Woonsocket, RI, United States, 02895 and employs 219,000 people. CVS Health is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

CVS Health Corp Leadership Team

Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
J Joyner, Executive Vice President
Shawn Guertin, Chief Financial Officer, Executive Vice President
Richard Bracken, Independent Director
Mary Schapiro, Independent Director
Laurence McGrath, Senior Relations
Norman Greve, Chief Officer
David Brown, Independent Director
William Weldon, Independent Director
Kevin Hourican, Executive Vice President, President of CVS Pharmacy
Larry McGrath, Sr Relations
Stephen Gold, Senior Vice President CIO
Joshua Flum, Executive Vice President, Chief Strategy and Business Development Officer
Troyen Brennan, Executive Vice President Chief Medical Officer
Prem Shah, Executive Vice President, Chief Pharmacy Officer and Co-President of Retail
Karen Lynch, President, Chief Executive Officer, Director
Thomas Moriarty, Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Per Lofberg, Executive Vice President
David Joyner, Executive Vice President
David Falkowski, Executive Officer
Prem PharmD, Chief VP
Jonathan Roberts, Chief Operating Officer, Executive Vice President
Alan Lotvin, Executive Vice President and Presidentident - CVS Caremark
Neela Montgomery, Executive Vice President and President - CVS Pharmacy/Retail
Alan MD, Ex Services
Andrew Sussman, Senior Vice President Associate Chief Medical Officer
Robert Kraft, Executive Vice President
Edward Ludwig, Independent Director
David Dorman, Independent Chairman of the Board
Richard Swift, Independent Director
Fernando Aguirre, Independent Director
Laurie Havanec, Chief People Officer, Executive Vice President
C Brown, Independent Director
NancyAnn DeParle, Independent Director
David CEBS, Executive Caremark
Tilak Mandadi, Data, Digital
Thomas Cowhey, Executive CFO
JeanPierre Millon, Independent Director
Mark Bertolini, Independent Director
Alecia DeCoudreaux, Independent Director
Samrat Esq, Chief VP
Lisa Bisaccia, Chief Human Resource Officer, Executive Vice President
David Denton, CFO and Executive VP
Helena Foulkes, Executive VP and President of CVS Pharmacy Inc
Tony White, Independent Director
Anne Finucane, Independent Director
Vijay Patel, Senior CoFounder
Derica Rice, Executive Vice President, President of CVS Caremark
James Clark, Senior Vice President - Controller, Chief Accounting Officer
Eva Boratto, Chief Financial Officer, Executive Vice President
Daniel Finke, Executive Vice President and Presidentident - Health Care Benefits Segment
Larry Merlo, President, Chief Executive Officer, Director
Roger Farah, Independent Director
Michelle Peluso, Executive Vice President, Chief Customer Officer and Co-President of Retail

CVS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

CVS Health Investors Sentiment

The influence of CVS Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in CVS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to CVS Health's public news can be used to forecast risks associated with an investment in CVS. The trend in average sentiment can be used to explain how an investor holding CVS can time the market purely based on public headlines and social activities around CVS Health Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
CVS Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for CVS Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average CVS Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on CVS Health.

CVS Health Implied Volatility

    
  26.34  
CVS Health's implied volatility exposes the market's sentiment of CVS Health Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if CVS Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that CVS Health stock will not fluctuate a lot when CVS Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CVS Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CVS Health's short interest history, or implied volatility extrapolated from CVS Health options trading.

Pair Trading with CVS Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Health will appreciate offsetting losses from the drop in the long position's value.

Moving against CVS Stock

  0.43MBIO Mustang Bio Report 3rd of April 2024 PairCorr
The ability to find closely correlated positions to CVS Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Health Corp to buy it.
The correlation of CVS Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CVS Health Corp is a strong investment it is important to analyze CVS Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CVS Health's future performance. For an informed investment choice regarding CVS Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CVS Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for CVS Stock analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is CVS Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Health. If investors know CVS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.10)
Dividend Share
2.42
Earnings Share
6.47
Revenue Per Share
277.528
Quarterly Revenue Growth
0.12
The market value of CVS Health Corp is measured differently than its book value, which is the value of CVS that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Health's value that differs from its market value or its book value, called intrinsic value, which is CVS Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Health's market value can be influenced by many factors that don't directly affect CVS Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if CVS Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.